According to interviews conducted with medical personnel with experience in caring for patients with chronic diseases, there is a consensus that despite patients receiving education on behavior modification, they often struggle to effectively control their conditions. Therefore, it is believed that effective treatment should begin with patient care at the pre-diabetic stage to delay the onset of diabetes. A preceding study in both in vitro and animal experimentation revealed that banana blossoms
Conditions
Interventions
The volunteer consumes 3 grams of banana blossom powder mixed with 150 ml of water per day for 8 weeks.,The volunteer consumes 2.5 grams of maltodextrin and caramel coloring powder mixed with 150 ml o
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Banana blossom powder,Placebo
Sponsors
Fundamental fund Kasetsart University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Individuals with fasting plasma glucose (FPG) levels between 100-125 mg/dl or hemoglobin A1C (HbA1C) levels between 5.7-6.4%. 2.Not consuming any herbal supplements for at least 1 month prior to participating in the study. 3.Not consuming any herbal supplements for at least 1 month prior to participating in the study. 4.Must be willing volunteers who are able to participate in follow-up tests and the study for a duration of 8 weeks
Exclusion criteria
Exclusion criteria: 1.Individuals with diabetes. 2.Patients with other causes leading to high blood sugar levels such as receiving steroids, having chronic liver disease. 3.Cancer patients undergoing treatment. 4.Patients with kidney disease with blood creatinine levels greater than or equal to 2 milligrams/deciliter or undergoing kidney replacement therapy. 5.Patients with chronic liver disease or having aspartate transaminase (AST) and alanine transaminase (ALT) enzymes levels greater than 3 times the normal value. 6.Taking medication affecting blood sugar levels. 7.Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose at 8 weeks after end of the intervention Blood analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin lipid profile BUN Cr liver function test At 8 weeks after end of the intervention Blood analysis | — |
Countries
Thailand
Contacts
Public ContactBandhita Wanikorn
Kasetsart University
Outcome results
None listed